Variable region domain exchange influences the functional properties of IgG

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2802-2808

  Morrison, Sherie L ^a   Porter, Stephen B ^b   Trinh, K Ryan ^a   Wims, Letitia A ^a   Denham, Jerrod ^a   Oi, Vernon T ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY;

ANTIGENS; COMPLEMENT ACTIVATION; DANSYL COMPOUNDS; DIMERIZATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032520783     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rowe, E. S. 1976. Dissociation and denaturation equilibria and kinetics of a homogeneous human immunoglobulin Fab fragment. Biochemistry 15:905.
2. Huber, R. 1980. Spatial structure of immunoglobulin molecules. Klin. Wochenschr. 58:1217.
3. Simon, T., and K. Rajewsky. 1990. Antibody domain mutants demonstrate autonomy of the antigen binding site. EMBO J. 9:1051.
4. Oi, V. T., and S. L. Morrison. Chimeric antibodies. BioTechniques 4:214.
5. Morrison, S. L., M. J. Johnson, L. A. Herzenberg, and V. T. Oi. 1984. Chimeric human antibody molecules: mouse antigen binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA 81:6851.
6. Dangl, J. L., T. G. Wensel, S. L. Morrison, L. Stryer, L. A. Herzenberg, and V. T Oi. 1988. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 7:1989.
7. Tan, L. K., R. J. Shopes, V. T. Oi, and S. L. Morrison. 1990. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. Proc. Natl. Acad. Sci. USA 87:162.
8. Angal, S., D. J. King, M. W. Bodmer, A. Turner, A. D. Lawson, G. Roberts, B. Pedley, and J. R. Adair. 1993. A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol. Immunol. 30:105.
9. Tao, M. H., and S. L. Morrison. 1989. Studies of aglycosylated chimenc mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143:2395.
10. Tao, M. H., S. M. Canfield, and S. L. Morrison. 1991. The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain. J. Exp. Med. 173:1025.
11. Tan, L. K., V. T. Oi, and S. L. Morrison. 1985. A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells. J. Immunol. 135:3564.
12. Wu, G. E., N. Hozumi, and H. Murialdo. 1983. Secretion of a λ2 immunoglobulin chain is prevented by a single amino acid substitution in its variable region. Cell 33:77.
13. Ma, J., J. F. Kearney, and L. M. Hendershot. 1990. Association of transport-defective light chains with immunoglobulin heavy chain binding protein. Mol. Immunol. 27:623.
14. Dul, J. L., and Y. Argon. 1990. A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion. Proc. Natl. Acad. Sci. USA 87:8135.
15. Bergman, L. W., and W. M. Kuehl. 1979. Co-translational modification of nascent immunoglobulin heavy and light chains. J. Supramol. Struct. 11:9.
16. Bigelow, C. C., B. R. Smith, and K. J. Dorrington. 1974. Equilibrium and kinetic aspects of subunit association in Immunoglobulin G. Biochemistry 13:4602.
17. Morrison, S. L., and M. D. Scharff. 1979. A mouse myeloma variant with a defect in light chain synthesis. Eur. J. Immunol. 9:461.
18. Stevenson, G. T., and K. J. Dorrington. 1970. The recombination of dimers of immunoglobulin peptide chains. Biochem. J. 118:703.
19. Dorrington, K. J., and B. R. Smith. 1972. Conformation changes accompanying the dissociation and association of immunoglobulin-G subunits. Biochim. Biophys. Acta 273:70.
20. Klein, M., C. Kortan, D. I. C. Kells, and K. J. Dorrington. 1979. Equilibrium and kinetic aspects of the interaction of isolated variable and constant domains of light chain with the Fd' fragment of immunoglobulin G. Biochemistry 18:1473.
21. Zolla, S., J. Buxbaum, E. C. Franklin, and M. D. Scharff. 1970. Synthesis and assembly of immunoglobulins by malignant human plasmacytes. I. Myelomas producing γ-chains and light chains. J. Exp. Med. 132:1482.
22. Phillips, M. L., V. T. Oi, and V. N. Schumaker. 1990. Electron microscopic study of ring-shaped bivalent hapten, bivalent antidansyl monoclonal antibody complexes with identical variable domains but IgG1, IgG2a and IgG2b constant domains. Mol. Immunol. 27:181.
23. Cooper, L. J., D. Robertson, R. Granzow, and N. S. Greenspan. 1994. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Mol. Immunol. 31:577.
24. Duncan, A. R., and G. Winter. 1988. The binding site for Clq on IgG. Nature 332:738.
25. Bruggemann, M., G. T. Williams, C. I. Bindon, M. R. Clark, M. R. Walker, R. Jefferis, H. Waldmann, and M. S. Neuberger. 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166:1351.
26. Bindon, C. I., G. Hale, M. Bruggemann, and H. Waldmann. 1988. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as Clq. J. Exp. Med. 168:127.
27. Bindon, C. I., G. Hale, and H. Waldmann. 1990. Complement activation by immunoglobulin does not depend solely on Clq binding. Eur. J. Immunol. 20: 277.
28. Horgan, C., K. Brown, and S. H. Pincus. 1990. Alteration in H chain V region affects complement activation by chimeric antibodies. J. Immunol. 145:2527.